News Column

CLEVELAND BIOLABS INC FILES (8-K) Disclosing Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders

June 16, 2014



Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

At the Annual Meeting of Stockholders of Cleveland Biolabs, Inc. (the "Company") held on June 11, 2014 (the "2014 Annual Meeting") in Buffalo, New York, David C. Hohn and Paul E. DiCorleto retired from the board of directors, following the expiration of their current terms.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The results of matters submitted to a stockholder vote at the 2014 Annual Meeting are as follows:

Proposal 1: Election of Directors. Nine nominees were elected to serve on the Company's Board of Directors until the next annual meeting of stockholders and until their successors are elected and qualified with the votes set forth below:

Nominee For Withheld Broker Non-Votes James J. Antal 9,554,576 4,738,966 23,814,958 Julia R. Brown 11,005,781 3,287,761 23,814,958 Andrei Gudkov 12,440,974 1,852,568 23,814,958 Daniel F. Hoth 11,811,569 2,481,973 23,814,958 Yakov Kogan 11,344,339 2,949,203 23,814,958 Richard S. McGowan 10,367,608 3,925,934 23,814,958 Anthony J. Principi 11,419,779 2,873,763 23,814,958 Alexander Polinsky 11,810,608 2,482,934 23,814,958 Randy S. Saluck 10,277,518 4,016,024 23,814,958



Proposal 2: Ratification of Meaden & Moore, Ltd. as the independent registered public accounting firm for the fiscal year ended December 31, 2014. The selection of Meaden & Moore, Ltd. as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2014 was ratified with the votes set forth below:

For Against Abstain 37,640,139 416,941 51,420



Proposal 3: Advisory vote to approve compensation of the named executive officers. The resolution relating to the non-binding stockholder advisory vote to approve the compensation of the Company's named executive officers, as described in the Proxy Statement, was approved with the votes set forth below:

For Against Abstain Broker Non-Votes 8,994,549 4,951,661 347,332 23,814,958



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters